tm
Seeing Is Believing
tm
Seeing Is Believing
ARTV is currently covered by 1 analysts with an average price target of $17.4. This is a potential upside of $11.99 (221.63%) from yesterday's end of day stock price of $5.41.
Artiva Biotherapeutics, Common Stock's activity chart (see below) currently has 2 price targets and 4 ratings on display. The stock rating distribution of ARTV is 100% BUY.
Highest price target for ARTV is $18, Lowest price target is $18, average price target is $18.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 17-Oct-2025. First documented stock forecast 13-Aug-2024.
Currently out of the existing stock ratings of ARTV, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$18
$11.99 (199.50%)
$23
7 days ago
(17-Oct-2025)
0/4 (0%)
$11.99 (199.50%)
What is ARTV (Artiva Biotherapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on ARTV (Artiva Biotherapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on ARTV (Artiva Biotherapeutics, Common Stock)?
Which analyst is the currently most bullish on ARTV (Artiva Biotherapeutics, Common Stock)?
